Ads
related to: vertex pharmaceuticals diabetes- FAQs
View frequently asked
questions and more.
- Savings
Find details on how to save
on a type 2 diabetes treatment.
- Patient Support
Support available when
& where you need it.
- Patient Resources
Download a savings
card online today.
- FAQs
Search results
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x?
Motley Fool via Yahoo Finance· 4 months agoI've been a big fan of Vertex Pharmaceuticals (NASDAQ: VRTX), and the biotech stock has made me a...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 4 weeks agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...
Vertex Pharmaceuticals (VRTX): A Fairly Valued Stock with Strong Growth Prospects
GuruFocus.com via Yahoo Finance· 10 months agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) saw a daily gain of 3.07%, with an Earnings Per Share (EPS)...
Is Vertex Pharmaceuticals a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has beaten the bear market by far this year: The stock is heading for a 30% gain. Vertex is the global leader in...
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie
Motley Fool· 1 year agoWhile the overall market plummeted last year, shares of Vertex Pharmaceuticals (NASDAQ: VRTX)...
Is Vertex Pharmaceuticals Stock a Buy Now?
Motley Fool via Yahoo Finance· 5 months agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) has delivered market-beating returns over the past 12 months, five years, and 10 years. Existing...
IBD Stock Of The Day: Vertex Briefly Breaks Out On Bullish Diabetes Data
Investor's Business Daily· 2 years agoRecent IBD Stock Of The Day Vertex Pharmaceuticals briefly broke out Wednesday on promising test...
Vertex (VRTX) Stock Poised Well for Growth in 2023: Here's Why
Zacks via Yahoo Finance· 12 months agoVertex Pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple...
Vertex (VRTX) to Begin Clinical Study on Type I Diabetes Drug
Zacks via Yahoo Finance· 1 year agoVertex Pharmaceuticals VRTX announced the clearance of an Investigational New Drug (IND) application...
Ad
related to: vertex pharmaceuticals diabetes
